Ingr Cancer Research Results
Ingr, Components/Ingredients: Click to Expand ⟱
| Source: |
| Type: |
| Main Active Components
|
Scientific Papers found: Click to Expand⟱
Ingr↝, TumCP↓, toxicity↓, *AntiDiabetic↑, *antiOx↑, *hepatoP↑, *diuretic↑, *Inflam↓, *neuroP↑, *Imm↑, eff↑, Apoptosis↑, tumCV↓, selectivity↑, TumCMig↓, EMT↓, MMP2↓, MMP9↓, Wnt↓, β-catenin/ZEB1↓, PI3K↓, Akt↓, JNK↓, ERK↓,
*cardioP↑, *Ingr↝, *Ingr↝, *toxicity∅, *toxicity↓, *BP↓, *Inflam↓, *Bacteria↓, *Imm↑, *lipid-P↓, *AST↓, *ALAT↓, *AntiAg↑, *ROS↓, *AntiThr↑,
*Ingr↝, *AntiCan↑, *AntiDiabetic↑, *AntiBio↑, *Inflam↓, *antiAll↑, *hepatoP↑, *cough?, *SoreThr?, *toxicity↝, *cardioP↑, *BioAv↝, *PGE2↓, *COX2/PTGS2↓, *AntiAg↑, *ROS↓, *NLRP3↓, *NF-kB↓, *AP-1↓, TumCCA↑, Apoptosis↑, TumMeta↑, *Dose↝, *Dose↝, Ingr↝, TumAuto↑, LC3II↑, PI3K↓, Akt↓, mTOR↓, *cognitive↑, *BloodF↑, ChemoSen↑, ROS↓, *chemoP↑, ROS↑, tumCV↓, MMP↓, *AntiBio↑, *toxicity↝,
| - |
in-vitro, |
GC, |
MGC803 |
|
|
|
- |
in-vitro, |
GC, |
BGC-823 |
|
|
|
- |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
Ingr↝, TumCP↓, TumCCA↑, Apoptosis↑, cycD1/CCND1↓, cycE/CCNE↓, BAX↑, PARP↑, proCasp3↑, proCasp8↑, proCasp9↑, Bcl-2↓, survivin↓, p65↓, p‑PI3K↓, p‑Akt↓,
*Ingr↝, *iNOS↓, *COX2/PTGS2↓, *IκB↓, *p65↓, *ERK↓, *p38↓, *MAPK↓, *PI3K↓, *Akt↓, *NF-kB↓,
*Ingr↝, *AntiViral↑, *AntiCan↑, *Inflam↓, TumCMig↓, TumCI↓, Akt↓, mTOR↓, STAT3↓, Dose↝,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
Ingr↝, 3,
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↓, 1, ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 3, p‑Akt↓, 1, Apoptosis↑, 3, BAX↑, 1, Bcl-2↓, 1, proCasp3↑, 1, proCasp8↑, 1, proCasp9↑, 1, JNK↓, 1, survivin↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 2,
Autophagy & Lysosomes(tgid=9) ⓘ
LC3II↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 1, cycE/CCNE↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
EMT↓, 1, ERK↓, 1, mTOR↓, 2, PI3K↓, 2, p‑PI3K↓, 1, STAT3↓, 1, Wnt↓, 1,
Migration(tgid=13) ⓘ
MMP2↓, 1, MMP9↓, 1, TumCI↓, 1, TumCMig↓, 2, TumCP↓, 2, TumMeta↑, 1, β-catenin/ZEB1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
p65↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, Dose↝, 1, eff↑, 1, selectivity↑, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 41
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
antiAll↑, 1, AntiBio↑, 2, cough?, 1, diuretic↑, 1, Ingr↝, 5, SoreThr?, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, lipid-P↓, 1, ROS↓, 2,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, iNOS↓, 1, MAPK↓, 1, p38↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
AntiThr↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ERK↓, 1, PI3K↓, 1,
Migration(tgid=13) ⓘ
AntiAg↑, 2, AP-1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 2, Imm↑, 2, Inflam↓, 4, IκB↓, 1, NF-kB↓, 2, p65↓, 1, PGE2↓, 1,
Protein Aggregation(tgid=19) ⓘ
NLRP3↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, Dose↝, 2,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1, BloodF↑, 1, BP↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 2, AntiDiabetic↑, 2, cardioP↑, 2, chemoP↑, 1, cognitive↑, 1, hepatoP↑, 2, neuroP↑, 1, toxicity↓, 1, toxicity↝, 2, toxicity∅, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiViral↑, 1, Bacteria↓, 1,
Total Targets: 45
Scientific Paper Hit Count for: Ingr, Components/Ingredients
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1794 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page